文献速递胃肠外科

机器人与腹腔镜根治性胃切除术长期结局的倾向性评分匹配研究

Comparison of long-term outcomes after robotic versus laparoscopic radical gastrectomy: a propensity score-matching study.
PubMed 文献 · Surg Endosc · 2022-06-28

该研究前瞻性收集并回顾性分析福建医科大学附属协和医院2016年7月至2018年7月接受机器人根治性胃切除术(RG)与腹腔镜根治性胃切除术(LG)的胃癌患者资料,经1:3倾向性评分匹配后RG组211例、LG组663例。主要终点为3年总生存(OS)与3年无复发生存(RFS),结果显示RG组3年OS率81.0%对LG组79.3%(P=0.516),3年RFS率78.7%对75.6%(P=0.600),亚组分析及淋巴结清扫治疗价值指数均无显著差异。结论认为RG可获得与LG相当的根治效果与长期结局。

要点

  • 匹配后RG组3年OS率81.0%、LG组79.3%,差异无统计学意义(P=0.516)。
  • 匹配后RG组3年RFS率78.7%、LG组75.6%,差异无统计学意义(P=0.600)。
  • 亚组分析中RG与LG的3年OS和3年RFS均无显著差异(均P>0.05)。

核心结论

  • 机器人根治性胃切除术可获得与腹腔镜手术相当的根治效果和长期结局。

研究设计与样本

  • 前瞻性收集、回顾性分析福建医科大学附属协和医院2016年7月至2018年7月胃癌患者资料。
  • RG队列与LG队列按1:3倾向性评分匹配,匹配后RG组211例、LG组663例。
  • 主要终点为3年总生存率和3年无复发生存率。

主要发现

  • 匹配后RG组3年OS率为81.0%,LG组为79.3%(log-rank检验,P=0.516)。
  • 匹配后RG组3年RFS率为78.7%,LG组为75.6%(log-rank检验,P=0.600)。
  • 亚组分析中RG与LG的3年OS和3年RFS均无显著差异(所有P>0.05)。
  • 机器人队列各淋巴结站清扫的治疗价值指数与腹腔镜队列相当。

关键数值与推荐

  • 3年OS率:RG组81.0%,LG组79.3%(P=0.516)。
  • 3年RFS率:RG组78.7%,LG组75.6%(P=0.600)。

临床怎么用

  • 在具备机器人手术条件的中心,RG可作为胃癌根治术的可选术式,其长期肿瘤学结局与LG相当。

局限性

  • 原文建议进一步开展多中心前瞻性研究评估机器人根治性胃切除术的临床疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is insufficient evidence to evaluate the long-term outcomes of robotic radical gastrectomy. The aim of this study was to compare the radical results and long-term outcomes of robotic and laparoscopic radical gastrectomy. METHODS: We prospectively collected and retrospectively analyzed the general clinicopathological data of gastric cancer patients treated with robotic radical gastrectomy (RG) and laparoscopic radical gastrectomy (LG) from July 2016 to July 2018 at Fujian Medical University Union Hospital. The RG cohort was matched 1:3 with the LG cohort by using propensity score matching (PSM). The primary endpoints of the study were 3-year overall survival (OS) and 3-year relapse-free survival (RFS). RESULTS: The study included 221 patients treated with RG and 1106 patients treated with LG for gastric cancer. After PSM, 211 patients were included in the RG cohort, and 663 patients were included in the LG cohort. The 3-year OS rate was 81.0% in the robotic cohort and 79.3% in the laparoscopic cohort (log-rank test, P = 0.516). The 3-year RFS rate was 78.7% in the robotic cohort and 75.6% in the laparoscopic cohort (log-rank test, P = 0.600). In the subgroup analyses, no significant differences were noted between the RG and LG cohorts in terms of 3-year OS and 3-year RFS (all P > 0.05). The therapeutic value index of each lymph node station dissection in the robotic cohort was comparable to that in the laparoscopic cohort. CONCLUSION: Robotic radical gastrectomy can achieve radical results and long-term outcomes comparable to laparoscopic surgery, and further multicenter prospective studies can be conducted to assess the clinical efficacy of robotic radical gastrectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Li JT, Lin JX, Wang FH, et al. Comparison of long-term outcomes after robotic versus laparoscopic radical gastrectomy: a propensity score-matching study. Surg Endosc. 2022. PMID: 35764839. doi:10.1007/s00464-022-09245-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。